ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

May 22, 2013 8:52 am by | 0 Comments

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for ... Read more

Pfizer’s Zoetis IPO is the biggest since Facebook went public

Pfizer’s Zoetis IPO is the biggest since Facebook went public

February 1, 2013 9:58 am by | 0 Comments

Pfizer had a fantastic week with the successful initial public offering of its animal health unit. The IPO raised $2.2 billion and shares closed at $31.01 Friday. ... Read more


Private equity group considerss Abu Dhabi healthcare IPO in 2013

Private equity group considerss Abu Dhabi healthcare IPO in 2013

December 19, 2012 9:40 am by | 0 Comments

DUBAI (Reuters) - The private equity consortium which owns half of Abu Dhabi healthcare provider Al Noor Medical is reviving plans to sell its stake through a stock market listing ... Read more

Founder lists lessons learned from a failed IPO

Founder lists lessons learned from a failed IPO

November 10, 2012 2:30 pm by | 0 Comments

After being delisted from the NASDAQ, Varsity Books pivoted to preserve the business. See what else the co-founder learned from his initial failure. ... Read more

Kidney protection device firm to raise $21.2M in Australian public offering

Kidney protection device firm to raise $21.2M in Australian public offering

March 8, 2012 10:42 am by | 0 Comments

A Minnesota medical device company whose products prevent kidneys from being affected from routine procedures related to angioplasty and stenting announced Thursday that it plans to raise more than $20 ... Read more

Diagnostics firm Metabolon raises $13M in series D; is IPO next?

Diagnostics firm Metabolon raises $13M in series D; is IPO next?

August 29, 2011 5:39 pm by | 0 Comments

Diagnostics firm Metabolon has raised $13.1 million in a fourth round of financing and in doing so has signaled intentions to eventually pursue an initial public stock offering.Metabolon added new ... Read more

N.C. diagnostics firm LipoScience files for $86M IPO

N.C. diagnostics firm LipoScience files for $86M IPO

June 24, 2011 10:27 am by | 0 Comments

Diagnostics company LipoScience aims to become North Carolina’s next public company.Raleigh, North Carolina-based LipoScience has filed with securities regulators plans to raise up to $86.2 million in an initial public ... Read more


Healthcare business funding could be derailed by weak IPO market

Healthcare business funding could be derailed by weak IPO market

June 23, 2011 3:53 pm by | 0 Comments

Venture capitalists have a message for healthcare entrepreneurs, and it reads like this:’If you’re considering an initial public offering, don’t.’That’s on the footsteps of a new study from Deloitte and ... Read more

IPOs make a comeback (Morning Read)

IPOs make a comeback (Morning Read)

April 27, 2011 8:30 am by | 0 Comments

Current medical news and unique business news for anyone who cares about the healthcare industry.A comeback for IPOs? At 31, monthly filings for U.S. initial public offerings in April are ... Read more

Biotech IPOs: One pulled back another starts flat (Weekend Rounds)

Biotech IPOs: One pulled back another starts flat (Weekend Rounds)

April 9, 2011 8:43 am by | 0 Comments

Life science current events this week include news on biotech IPOs including Aldagen and Tranzyme, Medtronic changes its cardiac and vascular sales forces, and the founder of AtriCure starts his ... Read more

Stem cell therapy firm Aldagen withdraws plans for $80M IPO

Stem cell therapy firm Aldagen withdraws plans for $80M IPO

April 5, 2011 1:54 pm by | 0 Comments

Stem cell therapy company Aldagen is pulling back on its plans for an initial public stock offering.The Durham, North Carolina-based company said in a Tuesday filing with the Securities and ... Read more

Tranzyme IPO targeted for April 4; offering re-priced at $4 per share

Tranzyme IPO targeted for April 4; offering re-priced at $4 per share

April 1, 2011 11:10 am by | 0 Comments

North Carolina’s next initial public offering will be Tranzyme Pharma, which expects to begin trading April 4.The company announced the date for the offering late today after earlier revising the ... Read more

NC’s next IPO? Tranzyme prices offering that could raise $65M

NC’s next IPO? Tranzyme prices offering that could raise $65M

March 9, 2011 1:44 pm by | 0 Comments

The initial public offering planned by North Carolina drug development company Tranzyme Pharma now has a price. Tranzyme expects to net proceeds of $53.8 million from an offering priced between ... Read more

Genomic device maker Fluidigm has IPO hopes

Genomic device maker Fluidigm has IPO hopes

December 16, 2010 7:14 am by | 0 Comments

Fluidigm Corp., a San Francisco-based genomic device maker, hopes to go public.The company, which attempted its first IPO during the thick of the financial crisis, earlier this month filed a ... Read more

IPO in the works for diagnostics firm BG Medicine

IPO in the works for diagnostics firm BG Medicine

December 10, 2010 7:11 pm by | 0 Comments

The $71.2 million initial public offering should be announced next week. The IPO would help launch the company's BGM Galectin-3 biomarker, which evaluates the risk of a heart attack. The ... Read more